CSPC PHARMACEUT.GR. ADR4 Capital Reinvestment Ratio
CSPC PHARMACEUT.GR. ADR4 capital reinvestment ratio. CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Capital Reinvestment Ratio of 0.39x as of December 2025, meaning it reinvests 0% of its operating cash flow (€5.83 Billion) in capital expenditures (€2.28 Billion). Check cash flow reinvestment rate of CSPC PHARMACEUT.GR. ADR4 to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Capital reinvestment ratio of CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. This chart tracks CSPC PHARMACEUT.GR. ADR4's Capital Reinvestment Ratio across 5 annual periods. Also explore CVGU net assets growth trend to track the company's year-over-year net asset growth rate.
CSPC PHARMACEUT.GR. ADR4 Capital Reinvestment Ratio by Year (2021–2025)
CSPC PHARMACEUT.GR. ADR4 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see CVGU cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +26.9% |
| 2022 | 0.36x | €7.63 Billion | €2.72 Billion | ▼ -5.9% |
| 2021 | 0.38x | €4.64 Billion | €1.76 Billion | — |